Top 10 Biopharma Streamlines Case Intake with High Data Extraction Accuracy within First Two Weeks  

Boston, Massachusetts, USA – June 25, 2025 – ArisGlobal, an AI-first technology company at the forefront of life sciences and creator of LifeSphere®, today announced that a top 10 global pharmaceutical company has implemented LifeSphere NavaX, marking a significant step forward in AI adoption for safety case processing. 

The organization will leverage NavaX-powered Advanced Intake to process approximately 350,000 adverse event cases annually. The GenAI-enabled solution uses Dynamic Data Extraction to automate the collection of safety data from diverse sources and formats. Within the first two weeks of implementation, case forms were processed with high accuracy in data extraction. As more cases are processed, high accuracy will enable greater levels of autonomous case processing and operational efficiency. 

The project was completed quickly — in just five months — exemplifying the speed, scalability, and global readiness of LifeSphere NavaX, along with the close strategic alignment between the two teams in driving advanced R&D IT solutions. 

“This launch showcases what is possible when vision, innovation, and execution come together with full force. At ArisGlobal, we take pride in not just talking about next-generation technology but operationalizing AI, delivering true value for global pharmaceutical companies,” said Aman Wasan, CEO of ArisGlobal. “This company is a true leader in accelerating scientific and digital transformation, and we’re proud to partner with them on modernizing their R&D IT ecosystem. By deploying the latest technologies to drive efficiency, cost savings, and insights, they’re not only optimizing operations but also making a meaningful impact on patients around the world.” 

NavaX is ArisGlobal’s AI engine, embedded across the LifeSphere® Unify platform. In pharmacovigilance, it powers end-to-end case automation to help life sciences organizations improve compliance, reduce manual effort, and deliver insights faster. 

This deployment underscores ArisGlobal’s leadership in AI-first solutions for life sciences and highlights the increasing role of intelligent automation in transforming global safety operations.